[Measurement of troponin I levels in suspected myocardial infarction]

L N Daae1, T Andreassen, L L Mehus

  • 1Klinisk kjemisk laboratorium, Diakonhjemmets sykehus, Oslo.

Insights

Serum cardiac troponin I measurements are highly sensitive for detecting cardiac cell injury. This biomarker is valuable for ruling out cardiac injury in patients suspected of myocardial infarction.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Medicine

Background:

  • Myocardial infarction diagnosis relies on clinical presentation and enzyme markers.
  • Elevated cardiac enzymes like creatine kinase (CK) and CK-isoenzyme MB (CK-MB) are traditional indicators.
  • There is a need for more sensitive and specific biomarkers for early cardiac injury detection.

Purpose of the Study:

  • To evaluate the diagnostic utility of serum cardiac troponin I (cTnI) in patients with suspected myocardial infarction.
  • To compare cTnI levels with conventional diagnostic methods, including CK and CK-MB.
  • To assess the sensitivity of cTnI in identifying cardiac cell injury.

Main Methods:

  • A prospective study involving 319 consecutive patients with suspected myocardial infarction.
  • Serum cTnI levels were measured and compared to established diagnoses.
  • Conventional cardiac enzyme analysis (CK and CK-MB) was performed.

Main Results:

  • 40 patients with cTnI > 20 µg/L all showed abnormal CK and CK-MB.
  • 50 patients with cTnI between 1.0-19.9 µg/L had various heart conditions, with only 12 showing abnormal CK.
  • cTnI demonstrated high sensitivity for detecting cardiac cell injury.

Conclusions:

  • Serum cardiac troponin I is a sensitive indicator of cardiac cell injury.
  • cTnI measurements are useful for ruling out cardiac injury in suspected myocardial infarction.
  • cTnI offers superior diagnostic value compared to traditional enzyme markers in this patient cohort.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...